News
Featured Topics
Lead story
Other featured articles
-
Study of “Revolving Door” in Washington Shows One-Third of HHS Appointees Leave for Industry Jobs
A new study from the USC Schaeffer Center and Harvard University is the first to examine the “revolving door” in health care.
Posted in -
Applying to be a USC AD/ADRD RCMAR Scientist
Since 2012, the Schaeffer Center has received $6.1 million in funding from the NIH to fund pilot projects by junior scholars focused on addressing disparities. This year we are seeking junior scientists concentrating on Alzheimer’s disease and related dementias in minority populations.
Posted in -
White House Names First 10 Drugs for Medicare Negotiations; USC Policy Experts Available to Discuss Market Impact
Medicare released the list of the first 10 drugs subject to price negotiations under the Inflation Reduction Act (IRA), aiming to reduce drug costs for Medicare enrollees and taxpayers.
Posted in -
Lower-Middle Class Americans Near Retirement are Worse Off Than 20 Years Ago, New USC and Columbia Study Shows
‘Forgotten middle’ Americans face poorer health, worse economic outcomes and lower homeownership rates, along with increased disability in old age.
Posted in
Past
-
Intensive Lifestyle Counseling and Education by Health Specialists Associated With Higher Employment Rate Among People With Type 2 Diabetes
USC Schaeffer Center research finds intensive lifestyle intervention for people with type 2 diabetes – including weekly counseling on diet and exercise – is associated with increased employment. Researchers say the results suggest the potential of better chronic disease management for improving long-term labor market outcomes.
Categorized in -
There’s an Easy Way to Increase Rates of COVID Booster Vaccinations
USC research finds that the answer to getting more shots into arms is just a text message or email away.
Categorized in -
Biosimilars Drug Market Isn’t Broken After All, USC Schaeffer Study Finds
Researchers looked at cancer therapy trastuzumab (Herceptin) and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
Categorized in -
Schaeffer Research Director Testifies at Congressional Hearing on Biomedical Innovation and Patient Access
Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.
-
Senate Finance Committee Explores Costly, Secretive Practices in the Drug Supply Chain
Karen Van Nuys testified at the hearing, calling transparency “an essential first step.”
-
Prominent Health Executive Tom Priselac Named Vice Chair of Schaeffer Center Advisory Board
Priselac, who is CEO and president of Cedars-Sinai, has served on the board since its inception in 2011.